AI assistant
Sending…
IN8BIO, INC. — Director's Dealing 2024
Feb 8, 2024
35200_dirs_2024-02-08_c366cf6f-75ee-4f85-845f-2324576cdcb4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IN8BIO, INC. (INAB)
CIK: 0001740279
Period of Report: 2024-02-07
Reporting Person: Goswami Trishna (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-02-07 | Employee Stock Option (right to buy) | $1.22 | A | 176000 | Acquired | 2034-02-07 | Common Stock (176000) | Direct |
Footnotes
F1: Twenty-five percent (25%) of the shares subject to the option shall vest on February 7, 2025 and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.